From avoiding digital health failure to BIO 2015: 5 must-read stories from MedCity News this week
Check out a recap of the BIO and Health Innovation conferences from MedHeads and other top stories from this week.
Check out a recap of the BIO and Health Innovation conferences from MedHeads and other top stories from this week.
Consider it more wondering aloud than anything close to an official announcement, but athenahealth CEO Jonathan Bush publicly mused Wednesday whether Epocrates might be more successful "outside of my management sphere."
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Physicians might be using more mobile healthcare apps, but the question of trust is one that still looms. An example of that comes this week in the form of a pharmacist’s biting review of an app from the powerhouse team of Epocrates and Athenahealth. The app in question, Bugs + Drugs, pairs Epocrates’ clinical content […]
athenahealth’s January acquisition of mobile health company Epocrates has generated its first market-ready byproduct, as the two brands today announced a joint mobile app called “Bugs + Drugs.” The app for physicians pairs Epocrates’ mobile mastery and clinical content with data from the more than 40 million medical records athenahealth (NASDAQ:ATHN) hosts in the cloud. […]
With its agreement to purchase Epocrates Inc. (NASDAQ:EPOC), health IT company athenahealth Inc. (NASDAQ:ATHN) is hoping to go mobile, expand its network of customers and strengthen its brand awareness among doctors. Epocrates, the maker of point-of-care reference apps, has accumulated a user base including about 330,000 doctors — the coveted target audience for athenahealth’s SaaS […]
It's no secret that American physicians are having a love affair with Apple's iPad mobile computing device.
Epocrates Inc. -- the San Mateo, California, company that makes mobile drug reference tools -- has acquired Modality Inc. in Durham, North Carolina, for $13.8 million in cash. Modality develops digital learning, assessment, training and reference applications for Apple iPad, iPhone and iPhone Touch mobile devices. Its acquisition will expand Epocrates' product portfolio and Apple app-development workforce.
Epocrates, a developer of mobile drug reference tools, registers for a $75 million initial public offering — again. Epocrates Inc. plans to go public — again. The company last week filed for an initial public offering that could bring in as much as $75 million, according to a Securities & Exchange Commission filing. Epocrates makes […]
Highlights of the important and the interesting from the world of healthcare: New health plans offer lower premiums, but fewer choices: Health insurers are pushing a new breed of plans that offer reduced premiums in return for a narrower choice of doctors. That could spell trouble for President Obama, who frequently repeated the idea that […]
New government regulations covering meaningful use of electronic medical records are winning kudos from EMR and healthcare providers alike, with few naysayers piping up. New regulations governing how healthcare providers can prove meaningful use of electronic medical records technology, a hallmark of President Barack Obama’s healthcare reform law, are winning praise from both EMR and […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.